Alteus Biogenics Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 25-07-2024
- Paid Up Capital ₹ 5.00 M
as on 25-07-2024
- Company Age 16 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 40.50 Cr
as on 25-07-2024
- Satisfied Charges ₹ 5.00 M
as on 25-07-2024
- Revenue 34.74%
(FY 2023)
- Profit 2.80%
(FY 2023)
- Ebitda 9.33%
(FY 2023)
- Net Worth 37.61%
(FY 2023)
- Total Assets 59.87%
(FY 2023)
About Alteus Biogenics
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹40.50 Cr. The company has closed loans amounting to ₹5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Abesh Mazumder, Nibedita Chakraborty, Debasish Mitra, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24100WB2008PTC125979
- Company No.
125979
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 May 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Alteus Biogenics?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abesh Mazumder  | Director | 26-May-2008 | Current |
| Nibedita Chakraborty | Director | 01-Jan-2014 | Current |
| Debasish Mitra | Director | 22-May-2008 | Current |
| Reetwija Chakraborty | Director | 01-Jan-2014 | Current |
| Soma Dev | Director | 01-Jan-2014 | Current |
Financial Performance and Corporate Structure Insights of Alteus Biogenics.
Alteus Biogenics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 34.74% increase. The company also saw a slight improvement in profitability, with a 2.8% increase in profit. The company's net worth Soared by an impressive increase of 37.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alteus Biogenics?
In 2023, Alteus Biogenics had a promoter holding of 95.00% and a public holding of 5.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Delon Distribution And Logistics Private LimitedActive 10 years 8 months
Abesh Mazumder is a mutual person
- Devysun Sales & Distribution Private LimitedActive 13 years 10 months
Abesh Mazumder is a mutual person
- Alteus Global LimitedActive 3 years 1 month
Nibedita Chakraborty, Debasish Mitra and 1 more are mutual person
- Ochre Blue Retail Private LimitedActive 33 years 12 days
Nibedita Chakraborty and Debasish Mitra are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 20 Dec 2023 | ₹17.00 Cr | Open |
Axis Bank Limited Creation Date: 27 Mar 2023 | ₹12.00 Cr | Open |
Deutsche Bank Ag Creation Date: 16 Sep 2015 | ₹3.44 M | Open |
How Many Employees Work at Alteus Biogenics?
Alteus Biogenics has a workforce of 292 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alteus Biogenics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alteus Biogenics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
